These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38932720)

  • 21. Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications.
    Ebadi M; Bullo S; Buskara K; Hussein MZ; Fakurazi S; Pastorin G
    Sci Rep; 2020 Dec; 10(1):21521. PubMed ID: 33298980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent.
    Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T
    Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxyurea-loaded Fe
    Chaghervand MM; Torbati MB; Shaabanzadeh M; Ahmadi A; Tafvizi F
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jan; 395(1):51-63. PubMed ID: 34661718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Idarubicin-loaded folic acid conjugated magnetic nanoparticles as a targetable drug delivery system for breast cancer.
    Gunduz U; Keskin T; Tansık G; Mutlu P; Yalcin S; Unsoy G; Yakar A; Khodadust R; Gunduz G
    Biomed Pharmacother; 2014 Jul; 68(6):729-36. PubMed ID: 25194441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyethylene Glycol-Chitosan Oligosaccharide-Coated Superparamagnetic Iron Oxide Nanoparticles: A Novel Drug Delivery System for Curcumin Diglutaric Acid.
    Sorasitthiyanukarn FN; Muangnoi C; Thaweesest W; Bhuket PRN; Jantaratana P; Rojsitthisak P; Rojsitthisak P
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31906490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy.
    Abdalla MO; Karna P; Sajja HK; Mao H; Yates C; Turner T; Aneja R
    J Control Release; 2011 Feb; 149(3):314-22. PubMed ID: 21047537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimuli-responsive hybrid cluster bombs of PEGylated chitosan encapsulated DOX-loaded superparamagnetic nanoparticles enabling tumor-specific disassembly for on-demand drug delivery and enhanced MR imaging.
    Xie P; Du P; Li J; Liu P
    Carbohydr Polym; 2019 Feb; 205():377-384. PubMed ID: 30446118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison inhibitory effects of cisplatin and MNPs-PEG-cisplatin on the adhesion capacity of bone metastatic breast cancer.
    Mokhtari MJ; Koohpeima F; Mohammadi H
    Chem Biol Drug Des; 2017 Oct; 90(4):618-628. PubMed ID: 28338288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and properties of magnetic nanotheranostics coated with polyethylene glycol/5-fluorouracil/layered double hydroxide.
    Ebadi M; Saifullah B; Buskaran K; Hussein MZ; Fakurazi S
    Int J Nanomedicine; 2019; 14():6661-6678. PubMed ID: 31695362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzyme-responsive mannose-grafted magnetic nanoparticles for breast and liver cancer therapy and tumor-associated macrophage immunomodulation.
    Darya GH; Zare O; Karbalaei-Heidari HR; Zeinali S; Sheardown H; Rastegari B
    Expert Opin Drug Deliv; 2024 Apr; 21(4):663-677. PubMed ID: 38680108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smart chitosan-folate hybrid magnetic nanoparticles for targeted delivery of doxorubicin to osteosarcoma cells.
    Amiryaghoubi N; Abdolahinia ED; Nakhlband A; Aslzad S; Fathi M; Barar J; Omidi Y
    Colloids Surf B Biointerfaces; 2022 Dec; 220():112911. PubMed ID: 36274396
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Hajiramezanali M; Atyabi F; Mosayebnia M; Akhlaghi M; Geramifar P; Jalilian AR; Mazidi SM; Yousefnia H; Shahhosseini S; Beiki D
    Int J Nanomedicine; 2019; 14():2591-2605. PubMed ID: 31040674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA binding and cytotoxicity studies of magnetic nanofluid containing antiviral drug oseltamivir.
    Shahabadi N; Shadkam M; Mansouri K
    J Biomol Struct Dyn; 2019 Jul; 37(11):2980-2988. PubMed ID: 30035676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis.
    Sebak S; Mirzaei M; Malhotra M; Kulamarva A; Prakash S
    Int J Nanomedicine; 2010 Sep; 5():525-32. PubMed ID: 20957217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
    Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
    ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving antiproliferative effect of the nevirapine on Hela cells by loading onto chitosan coated magnetic nanoparticles as a fully biocompatible nano drug carrier.
    Moghadam NH; Salehzadeh S; Rakhtshah J; Tanzadehpanah H; Moghadam AH; Hajibabaei F; Sharifinia S; Asl SS; Saidijam M
    Int J Biol Macromol; 2018 Oct; 118(Pt A):1220-1228. PubMed ID: 30001607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blocking Interleukin-4 Receptor α Using Polyethylene Glycol Functionalized Superparamagnetic Iron Oxide Nanocarriers to Inhibit Breast Cancer Cell Proliferation.
    Shaik AP; Shaik AS; Majwal AA; Faraj AA
    Cancer Res Treat; 2017 Apr; 49(2):322-329. PubMed ID: 27456946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chitosan-coated magnetic nanoparticles as carriers of 5-fluorouracil: preparation, characterization and cytotoxicity studies.
    Zhu L; Ma J; Jia N; Zhao Y; Shen H
    Colloids Surf B Biointerfaces; 2009 Jan; 68(1):1-6. PubMed ID: 19013060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation of an efficient and safe polymeric-magnetic nanoparticle delivery system for sorafenib in hepatocellular carcinoma.
    Tom G; Philip S; Isaac R; Praseetha PK; Jiji SG; Asha VV
    Life Sci; 2018 Aug; 206():10-21. PubMed ID: 29709652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro cytotoxicity and anti-cancer drug release behavior of methionine-coated magnetite nanoparticles as carriers.
    Eshrati Yeganeh F; Eshrati Yeganeh A; Fatemizadeh M; Farasati Far B; Quazi S; Safdar M
    Med Oncol; 2022 Oct; 39(12):252. PubMed ID: 36224407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.